RPG Life Sciences Limited (RPGLIFE) — Announcement | 27 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Independent director's term ends after two five-year periods
🔄 What Changed
Sustainability and CSR Committee reconstituted with new members
💡 Investor Takeaway
Shareholders should note this is a standard governance update with no financial impact.

RPG Life Sciences announced the end of Independent Director Zahabiya Khorakiwala's second consecutive five-year term effective July 26, 2026, triggering a board committee reshuffle. Her departure from the Sustainability and CSR Committee concludes a tenure that began in 2021, with new committee members named in the filing. The change reflects routine governance updates under SEBI disclosure rules rather than performance issues, maintaining board continuity while updating committee composition.

📄 View Original Announcement (PDF)

About RPG Life Sciences Limited (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,254.99 Cr P/E: 35.6 ROE: 19.8% ROCE: 25.8% Div Yield: 0.93%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

📊 More RPGLIFE filings

See all RPGLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day